MJ Schell

1.3k total citations
17 papers, 1000 citations indexed

About

MJ Schell is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Molecular Biology. According to data from OpenAlex, MJ Schell has authored 17 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Public Health, Environmental and Occupational Health, 13 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in MJ Schell's work include Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (10 papers) and Hematopoietic Stem Cell Transplantation (4 papers). MJ Schell is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Acute Myeloid Leukemia Research (10 papers) and Hematopoietic Stem Cell Transplantation (4 papers). MJ Schell collaborates with scholars based in United States. MJ Schell's co-authors include GK Rivera, WM Crist, FG Behm, J Mirro, C-H Pui, Joseph Mirro, Victor M. Santana, Raymond L. Blakley, DR Head and SC Raimondi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PubMed.

In The Last Decade

MJ Schell

17 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
MJ Schell United States 14 636 535 258 191 184 17 1000
JH Kersey United States 9 636 1.0× 458 0.9× 178 0.7× 147 0.8× 282 1.5× 9 890
H. Baurmann Germany 18 757 1.2× 294 0.5× 211 0.8× 170 0.9× 180 1.0× 61 1.2k
SE Sallan United States 11 609 1.0× 775 1.4× 251 1.0× 218 1.1× 322 1.8× 14 1.4k
E. Odenwald Germany 11 483 0.8× 681 1.3× 276 1.1× 84 0.4× 138 0.8× 17 1.1k
NA Heerema United States 14 573 0.9× 705 1.3× 136 0.5× 162 0.8× 231 1.3× 21 998
Keiko Yumura‐Yagi Japan 18 605 1.0× 383 0.7× 332 1.3× 155 0.8× 201 1.1× 49 1.2k
J Mirro United States 18 882 1.4× 695 1.3× 242 0.9× 325 1.7× 346 1.9× 21 1.3k
J R Downing United States 15 880 1.4× 917 1.7× 186 0.7× 161 0.8× 519 2.8× 19 1.4k
GK Rivera United States 11 576 0.9× 794 1.5× 128 0.5× 126 0.7× 232 1.3× 11 1.1k
ME Trigg United States 12 636 1.0× 676 1.3× 199 0.8× 110 0.6× 84 0.5× 21 1.0k

Countries citing papers authored by MJ Schell

Since Specialization
Citations

This map shows the geographic impact of MJ Schell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MJ Schell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MJ Schell more than expected).

Fields of papers citing papers by MJ Schell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MJ Schell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MJ Schell. The network helps show where MJ Schell may publish in the future.

Co-authorship network of co-authors of MJ Schell

This figure shows the co-authorship network connecting the top 25 collaborators of MJ Schell. A scholar is included among the top collaborators of MJ Schell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MJ Schell. MJ Schell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Stute, Norbert, et al.. (1992). Pharmacokinetics of subcutaneous recombinant human granulocyte colony- stimulating factor in children. Blood. 79(11). 2849–2854. 76 indexed citations
2.
Santana, Victor M., J Mirro, Cristin Kearns, et al.. (1992). 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia.. Journal of Clinical Oncology. 10(3). 364–370. 120 indexed citations
3.
4.
Schell, MJ, et al.. (1992). Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood. 79(4). 871–875. 51 indexed citations
5.
Schell, MJ, et al.. (1992). Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood. 79(4). 871–875. 56 indexed citations
6.
Hurwitz, Craig A., Robert A. Krance, MJ Schell, et al.. (1992). Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital.. PubMed. 6 Suppl 2. 39–43. 13 indexed citations
7.
Pui, CH, AJ Carroll, SC Raimondi, et al.. (1992). Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Blood. 79(9). 2384–2391. 1 indexed citations
8.
Pui, C-H, AJ Carroll, SC Raimondi, et al.. (1992). Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Blood. 79(9). 2384–2391. 35 indexed citations
9.
Stute, Norbert, et al.. (1992). Pharmacokinetics of subcutaneous recombinant human granulocyte colony- stimulating factor in children. Blood. 79(11). 2849–2854. 58 indexed citations
10.
Pui, C-H, SC Raimondi, DR Head, et al.. (1991). Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse [see comments]. Blood. 78(5). 1327–1337. 93 indexed citations
11.
Santana, Victor M., J Mirro, Franklin C. Harwood, et al.. (1991). A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.. Journal of Clinical Oncology. 9(3). 416–422. 84 indexed citations
12.
Pui, C-H, SC Raimondi, DR Head, et al.. (1991). Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse [see comments]. Blood. 78(5). 1327–1337. 128 indexed citations
13.
Dahl, G V, David K. Kalwinsky, Joseph Mirro, et al.. (1990). Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.. Journal of Clinical Oncology. 8(2). 295–303. 47 indexed citations
14.
Pui, CH, FG Behm, Bikramjit Singh, et al.. (1990). Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood. 75(1). 174–179. 124 indexed citations
15.
Pui, CH, FG Behm, Bikramjit Singh, et al.. (1990). Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood. 75(1). 174–179. 10 indexed citations
16.
17.
Pui, Ching‐Hon, David K. Kalwinsky, MJ Schell, et al.. (1988). Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome.. Journal of Clinical Oncology. 6(6). 1008–1013. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JH Kersey Breakdown of academic impact, for papers by H. Baurmann Breakdown of academic impact, for papers by SE Sallan Breakdown of academic impact, for papers by E. Odenwald Breakdown of academic impact, for papers by NA Heerema Breakdown of academic impact, for papers by Keiko Yumura‐Yagi Breakdown of academic impact, for papers by J Mirro Breakdown of academic impact, for papers by J R Downing Breakdown of academic impact, for papers by GK Rivera Breakdown of academic impact, for papers by ME Trigg
Rankless by CCL
2026